Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer

In the scenario of systemic treatment for advanced non-small cell lung cancer (NSCLC) patients, one of the most relevant breakthroughs is represented by targeted therapies. Throughout the last years, inhibitors of the epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), c-Ros o...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Mol Sci
Glavni autori: Rebuzzi, Sara Elena, Zullo, Lodovica, Rossi, Giovanni, Grassi, Massimiliano, Murianni, Veronica, Tagliamento, Marco, Prelaj, Arsela, Coco, Simona, Longo, Luca, Dal Bello, Maria Giovanna, Alama, Angela, Dellepiane, Chiara, Bennicelli, Elisa, Malapelle, Umberto, Genova, Carlo
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7961376/
https://ncbi.nlm.nih.gov/pubmed/33807876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22052625
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items